Page last updated: 2024-08-16

tibolone and Local Neoplasm Recurrence

tibolone has been researched along with Local Neoplasm Recurrence in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (69.23)29.6817
2010's4 (30.77)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E; Wilkinson, J1
Beckmann, MW; Bundred, NJ; Egberts, J; Foidart, JM; Kenemans, P; Kubista, E; Mol-Arts, M; Mulder, R; Sismondi, P; van Os, S; Vassilopoulou-Sellin, R; von Schoultz, B; Yip, CH1
Goodwin, PJ1
Antsaklis, A; Dimitrakakis, C; Keramopoulos, D; Tsigginou, A1
Beckmann, MW; Bundred, NJ; Foidart, JM; Galta, RE; Kenemans, P; Kubista, E; Lieshout, EV; Mol-Arts, M; Planellas, J; Schoultz, Bv; Sismondi, P; Vassilopoulou-Sellin, R; Yip, CH1
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E1
Agorastos, T; Bontis, J; Dinas, K; Vaitsi, V; Vakiani, A1
Metsä-Heikkilä, M; Ylikorkala, O1
Bundred, NJ; Turner, LE1
Bundred, N; Fentiman, IS; Foidart, JM; Helmond, FA; Kroiss, R; Kubista, E; Mol-Arts, M; Rymer, J1
Anderson, GL; Chlebowski, RT1
Bredakis, N; Dimitrakakis, C; Gaki, V; Keramopoulos, A; Keramopoulos, D; Vourli, G1
Beckmann, MW; Bundred, NJ; Egberts, J; Foidart, JM; Kenemans, P; Kubista, E; Planellas, J; Sismondi, P; van Os, S; Vassilopoulou-Sellin, R; von Schoultz, B; Yip, CH1

Reviews

4 review(s) available for tibolone and Local Neoplasm Recurrence

ArticleYear
Short-term and long-term effects of tibolone in postmenopausal women.
    The Cochrane database of systematic reviews, 2016, Oct-12, Volume: 10

    Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Stroke; Sweating; Uterine Hemorrhage

2016
Short and long term effects of tibolone in postmenopausal women.
    The Cochrane database of systematic reviews, 2012, Feb-15, Issue:2

    Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Stroke; Sweating; Uterine Hemorrhage

2012
Hormone replacement therapy in women with a history of breast cancer.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2002, Volume: 16, Issue:6

    Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Quality of Life; Risk Factors; Selective Estrogen Receptor Modulators

2002
Postmenopausal hormone therapy before and after breast cancer: clinical experiences.
    Maturitas, 2004, Sep-24, Volume: 49, Issue:1

    Topics: Breast Neoplasms; Female; Hormone Replacement Therapy; Humans; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators

2004

Trials

6 trial(s) available for tibolone and Local Neoplasm Recurrence

ArticleYear
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
    The Lancet. Oncology, 2009, Volume: 10, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Osteoporosis, Postmenopausal; Vasomotor System

2009
What have we really learned from 'LIBERATE' trial?
    Maturitas, 2010, Volume: 66, Issue:1

    Topics: Breast Neoplasms; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes

2010
Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy.
    Breast cancer research : BCR, 2012, Jan-17, Volume: 14, Issue:1

    Topics: Adult; Aged; Analysis of Variance; Body Mass Index; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Osteoporosis; Selective Estrogen Receptor Modulators; Survivors

2012
The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
    BJOG : an international journal of obstetrics and gynaecology, 2005, Volume: 112, Issue:2

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Endometrium; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Hyperhidrosis; Lipids; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Pilot Projects; Postmenopause; Tamoxifen

2005
Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:4

    Topics: Adult; Aged; Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Prospective Studies; Tamoxifen

2005
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.
    Breast (Edinburgh, Scotland), 2007, Volume: 16 Suppl 2

    Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Autonomic Nervous System Diseases; Bone Density; Breast Neoplasms; Double-Blind Method; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Norpregnenes; Quality of Life; Survival Analysis; Tamoxifen; Treatment Outcome; Vasomotor System

2007

Other Studies

3 other study(ies) available for tibolone and Local Neoplasm Recurrence

ArticleYear
Tibolone: the risk is too high.
    The Lancet. Oncology, 2009, Volume: 10, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Estrogen Replacement Therapy; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Risk

2009
Atypical endometrial hyperplasia in an 18-year-old woman.
    Archives of gynecology and obstetrics, 2003, Volume: 267, Issue:4

    Topics: Adolescent; Clomiphene; Diagnosis, Differential; Endometrial Hyperplasia; Female; Humans; Leuprolide; Neoplasm Recurrence, Local; Norpregnenes; Precancerous Conditions; Progestins; Ultrasonography

2003
Progestins and recurrence in breast cancer survivors.
    Journal of the National Cancer Institute, 2005, Apr-06, Volume: 97, Issue:7

    Topics: Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Europe; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Progestins; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Survivors; Treatment Outcome

2005